Evidence map›Paper›PMID 39235058›Full record

ArticleFuture microbiology2024

Expression of

Preeti Maurya, Mohit Kumar, Ravi Jain, Haider Thaer Abdulhameed Almuqdadi, Harshita Singh, Aashima Gupta, Christoph Arenz, Naseem A Gaur, Shailja Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Selective targeting ofAntimicrobial agents and chemotherapy · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Preeti MauryaSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.ORCID 0009-0005-2462-9334
Mohit KumarYeast Biofuel Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, 110067, India.
Ravi JainSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.ORCID 0000-0001-7844-1031
Haider Thaer Abdulhameed AlmuqdadiMedicinal Chemistry Laboratory, Department of Bioscience, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.ORCID 0009-0008-3743-7480
Harshita SinghSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.
Aashima GuptaSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.
Christoph ArenzInstitut für Chemie, Humboldt-Universität zu Berlin, Berlin, 12489, Germany.
Naseem A GaurYeast Biofuel Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, 110067, India.
Shailja SinghSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, 110067, India.ORCID 0000-0001-5286-6605

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR46993/PBD/26/834/2023
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsAntimalarialsCandida glabrataMembrane Transport ProteinsPlasmodium falciparumCell MembraneFungal ProteinsHumansItraconazoleKetoconazoleProtozoan ProteinsAntifungal AgentsAntimalarialsFungal ProteinsItraconazoleKetoconazoleMembrane Transport ProteinsProtozoan ProteinsantimalarialCandida glabratadrug discoverymembrane transporterorthologous systemPlasmodium falciparum

Identifiers

PMID39235058
PMCPMC11485967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.